{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:12:19Z","timestamp":1787505139945,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.diabres.2022.110046","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:25:20Z","timestamp":1661300720000},"page":"110046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA \u2013 Brasil)"],"prefix":"10.1016","volume":"191","author":[{"given":"Maria de F\u00e1tima","family":"Haueisen Sander Diniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alline","family":"M.R. Beleigoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Isabel Rodrigues Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Weiss Telles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"In\u00eas Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"B. Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"M. Bense\u00f1or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio","family":"Luiz P. Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro G.","family":"Vidigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhi","family":"Maria Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.diabres.2022.110046_b0005","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.diabres.2022.110046_b0010","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"issue":"27","key":"10.1016\/j.diabres.2022.110046_b0015","doi-asserted-by":"crossref","first-page":"e4010","DOI":"10.1097\/MD.0000000000004010","article-title":"Factors associated with metabolically healthy status in obesity, overweight, and normal weight at baseline of ELSA-Brasil","volume":"95","author":"Diniz","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.diabres.2022.110046_b0020","doi-asserted-by":"crossref","unstructured":"Wong JC, O\u2019Neill S, Beck BR, Forwood MR, Khoo SK. Comparison of obesity and metabolic syndrome prevalence using fat mass index, body mass index and percentage body fat. PLoS One. 2021;16(1):e0245436. doi: 10.1371\/journal.pone.0245436. eCollection 2021.","DOI":"10.1371\/journal.pone.0245436"},{"key":"10.1016\/j.diabres.2022.110046_b0025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2458-14-14","article-title":"Beyond BMI: The \u201cMetabolically healthy obese\u201d phenotype & its association with clinical\/subclinical cardiovascular disease and all-cause mortality - a systematic review","volume":"14","author":"Roberson","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.diabres.2022.110046_b0030","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.metabol.2015.03.009","article-title":"Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes","volume":"64","author":"Eckel","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2022.110046_b0035","first-page":"1","article-title":"Review of hyperuricemia as new marker for metabolic syndrome","volume":"2014","author":"Billiet","year":"2014","journal-title":"ISRN Rheumatol 2014;2014:852954"},{"issue":"7","key":"10.1016\/j.diabres.2022.110046_b0040","first-page":"3167","article-title":"Update on the epidemiology, genetics, and therapeutic options of hyperuricemia","volume":"12","author":"Li","year":"2020","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.diabres.2022.110046_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.07.006","article-title":"Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease","volume":"80","author":"Borghi","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.diabres.2022.110046_b0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.diabres.2022.110046_b0055","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00392-021-01815-0","article-title":"The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk","volume":"110","author":"Pugliese","year":"2021","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"10.1016\/j.diabres.2022.110046_b0060","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1381612825666190408122557","article-title":"Hyperuricemia and cardiovascular disease","volume":"25","author":"Zhang","year":"2019","journal-title":"Curr Pharm Des"},{"issue":"16","key":"10.1016\/j.diabres.2022.110046_b0065","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/1381612827666210104124320","article-title":"Serum uric acid and diabetes: from pathophysiology to cardiovascular disease","volume":"27","author":"Katsiki","year":"2021","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.diabres.2022.110046_b0070","doi-asserted-by":"crossref","first-page":"e000157","DOI":"10.1161\/JAHA.113.000157","article-title":"Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009\u20132010","volume":"3","author":"Krishnan","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diabres.2022.110046_b0075","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.diabres.2022.110046_b0080","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1038\/ncomms5642","article-title":"Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9","volume":"5","author":"DeBosch","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.diabres.2022.110046_b0085","doi-asserted-by":"crossref","unstructured":"Sluijs I, Holmes MV, van der Schouw YT, Beulens JWJ, Asselbergs FW, Huerta JM, et al. InterAct Consortium. A Mendelian randomization study of circulating uric acid and type 2 diabetes. Diabetes 2015; 64:3028\u20133036. 2015 Apr 27, doi: 10.2337\/db14-0742. Epub 2015 Apr 27.","DOI":"10.2337\/db14-0742"},{"issue":"7","key":"10.1016\/j.diabres.2022.110046_b0090","doi-asserted-by":"crossref","first-page":"e2547","DOI":"10.1210\/clinem\/dgab200","article-title":"Genetic predisposition to type 2 diabetes and insulin levels is positively associated with serum urate levels","volume":"106","author":"Zhu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.diabres.2022.110046_b0095","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.amjmed.2014.02.031","article-title":"Is uric acid an underdiagnosed mediator of adverse outcome in metabolically healthy overweight\/obese individuals?","volume":"127","author":"Fini","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2022.110046_b0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jclinepi.2021.01.009","article-title":"Clinical prediction models: diagnosis versus prognosis","volume":"132","author":"van Smeden","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.diabres.2022.110046_b0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/aje\/kwr294","article-title":"Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): objectives and design","volume":"175","author":"Aquino","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.diabres.2022.110046_b0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/BOR.0000000000000028","article-title":"Definition of hyperuricemia and gouty conditions","volume":"26","author":"Bardin","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.diabres.2022.110046_b0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5603\/CJ.2018.0116","article-title":"Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk","volume":"25","author":"Borghi","year":"2018","journal-title":"Cardiol J"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2022.110046_b0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/S0034-8910.2013047003807","article-title":"Logistics of collection and transportation of biological samples and the organization of the central laboratory in the ELSA-Brasil","volume":"47","author":"Fedeli","year":"2013","journal-title":"Rev Saude Publica"},{"issue":"2","key":"10.1016\/j.diabres.2022.110046_b0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1590\/S1415-52732013000200005","article-title":"Diet assessment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil): Development of a food frequency questionnaire","volume":"26","author":"Molina","year":"2013","journal-title":"Rev Nutr"},{"key":"10.1016\/j.diabres.2022.110046_b0130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its associated cutoff point","volume":"47","author":"Fluss","year":"2005","journal-title":"Biom J"},{"key":"10.1016\/j.diabres.2022.110046_b0135","doi-asserted-by":"crossref","first-page":"14325","DOI":"10.1038\/srep14325","article-title":"Dose-response relationship of serum uric acid with metabolic syndrome and non-alcoholic fatty liver disease incidence: a meta-analysis of prospective studies","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.diabres.2022.110046_b0140","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00380-013-0386-2","article-title":"Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population","volume":"29","author":"Oda","year":"2014","journal-title":"Heart Vessels"},{"key":"10.1016\/j.diabres.2022.110046_b0145","doi-asserted-by":"crossref","unstructured":"Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO, Solbu MD. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Troms\u00f8 Study. BMC Cardiovasc Disord 2016;16:85. doi: 10.1186\/s12872-016-0265-8. PMID: 27165776.","DOI":"10.1186\/s12872-016-0265-8"},{"issue":"2","key":"10.1016\/j.diabres.2022.110046_b0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","article-title":"Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 Years","volume":"75","author":"Virdis","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.diabres.2022.110046_b0155","doi-asserted-by":"crossref","unstructured":"Tikhonoff V, Casiglia E, Spinella P, Barbagallo CM, Bombelli M, Cicero AFG et al. Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA). Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study. J Hum Hypertens. 2021 Sep 29. doi: 10.1038\/s41371-021-00613-5. Online ahead of print.","DOI":"10.1038\/s41371-021-00613-5"},{"issue":"5","key":"10.1016\/j.diabres.2022.110046_b0160","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.numecd.2022.01.028","article-title":"from the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension. Serum uric acid levels threshold for mortality in diabetic individuals: The URic acid Right for heArt Health (URRAH) project","volume":"32","author":"Masulli","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabres.2022.110046_b0165","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12020-022-02979-z","article-title":"The bidirectional relationship between metabolic syndrome and hyperuricemia in China: A longitudinal study from CHARLS","volume":"76","author":"Chen","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.diabres.2022.110046_b0170","doi-asserted-by":"crossref","first-page":"11529","DOI":"10.1038\/s41598-018-29955-w","article-title":"Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study","volume":"8","author":"Cicero","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2022.110046_b0175","doi-asserted-by":"crossref","first-page":"3175418","DOI":"10.1155\/2019\/3175418","article-title":"Lack of associations between elevated serum uric acid and components of metabolic syndrome such as hypertension, dyslipidemia, and T2DM in overweight and obese Chinese adults","volume":"2019","author":"Li","year":"2019","journal-title":"J Diabetes Res"},{"issue":"10","key":"10.1016\/j.diabres.2022.110046_b0180","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2337\/db12-1814","article-title":"Sugar, uric acid, and the etiology of diabetes and obesity","volume":"62","author":"Johnson","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2022.110046_b0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2022.110046_b0190","doi-asserted-by":"crossref","first-page":"110795","DOI":"10.1016\/j.biopha.2020.110795","article-title":"Recent advances in fructose intake and risk of hyperuricemia","volume":"131","author":"Zhang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.diabres.2022.110046_b0195","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/dme.12970","article-title":"Dairy consumption and risk of metabolic syndrome: a meta-analysis","volume":"33","author":"Kim","year":"2016","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.diabres.2022.110046_b0200","first-page":"1344","article-title":"Dietary factors and risk of gout and hyperuricemia: a meta-analysis and systematic review","volume":"27","author":"Li","year":"2018","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.diabres.2022.110046_b0205","doi-asserted-by":"crossref","unstructured":"-. Silva MTD, Diniz MFHS, Coelho CG, Vidigal PG, Telles RW, Barreto SM. Intake of selected foods and beverages and serum uric acid levels in adults: ELSA-Brasil (2008-2010). Public Health Nutr 2020 Feb;23(3):506-514. doi: 10.1017\/S1368980019002490. Epub 2019 Oct 7.","DOI":"10.1017\/S1368980019002490"},{"key":"10.1016\/j.diabres.2022.110046_b0210","doi-asserted-by":"crossref","unstructured":"Molina M del C, Bense\u00f1or IM, Cardoso LO, Velasquez-Melendez G, Drehmer M, Pereira TSS et al. Reproducibility and relative validity of the Food Frequency Questionnaire used in the ELSA-Brasil. Cad Saude Publica 2013;29(2):379-89. doi.org\/10.1590\/S0102-311X2013000200024.","DOI":"10.1590\/S0102-311X2013000200024"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722008609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:24:56Z","timestamp":1759173896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722008609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":42,"alternative-id":["S0168822722008609"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110046","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum uric acid is a predictive biomarker of incident metabolic syndrome at the Brazilian longitudinal study of adult Health (ELSA \u2013 Brasil)","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.110046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110046"}}